225 related articles for article (PubMed ID: 28593990)
1. Loss of Asxl2 leads to myeloid malignancies in mice.
Li J; He F; Zhang P; Chen S; Shi H; Sun Y; Guo Y; Yang H; Man N; Greenblatt S; Li Z; Guo Z; Zhou Y; Wang L; Morey L; Williams S; Chen X; Wang QT; Nimer SD; Yu P; Wang QF; Xu M; Yang FC
Nat Commun; 2017 Jun; 8():15456. PubMed ID: 28593990
[TBL] [Abstract][Full Text] [Related]
2. ASXL2 is essential for haematopoiesis and acts as a haploinsufficient tumour suppressor in leukemia.
Micol JB; Pastore A; Inoue D; Duployez N; Kim E; Lee SC; Durham BH; Chung YR; Cho H; Zhang XJ; Yoshimi A; Krivtsov A; Koche R; Solary E; Sinha A; Preudhomme C; Abdel-Wahab O
Nat Commun; 2017 May; 8():15429. PubMed ID: 28516957
[TBL] [Abstract][Full Text] [Related]
3. Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromes.
Chesnais V; Arcangeli ML; Delette C; Rousseau A; Guermouche H; Lefevre C; Bondu S; Diop M; Cheok M; Chapuis N; Legros L; Raynaud S; Willems L; Bouscary D; Lauret E; Bernard OA; Kosmider O; Pflumio F; Fontenay M
Blood; 2017 Jan; 129(4):484-496. PubMed ID: 27856460
[TBL] [Abstract][Full Text] [Related]
4. Bcor loss perturbs myeloid differentiation and promotes leukaemogenesis.
Kelly MJ; So J; Rogers AJ; Gregory G; Li J; Zethoven M; Gearhart MD; Bardwell VJ; Johnstone RW; Vervoort SJ; Kats LM
Nat Commun; 2019 Mar; 10(1):1347. PubMed ID: 30902969
[TBL] [Abstract][Full Text] [Related]
5. Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts.
Kode A; Manavalan JS; Mosialou I; Bhagat G; Rathinam CV; Luo N; Khiabanian H; Lee A; Murty VV; Friedman R; Brum A; Park D; Galili N; Mukherjee S; Teruya-Feldstein J; Raza A; Rabadan R; Berman E; Kousteni S
Nature; 2014 Feb; 506(7487):240-4. PubMed ID: 24429522
[TBL] [Abstract][Full Text] [Related]
6. Low-level GATA2 overexpression promotes myeloid progenitor self-renewal and blocks lymphoid differentiation in mice.
Nandakumar SK; Johnson K; Throm SL; Pestina TI; Neale G; Persons DA
Exp Hematol; 2015 Jul; 43(7):565-77.e1-10. PubMed ID: 25907033
[TBL] [Abstract][Full Text] [Related]
7. Phf6-null hematopoietic stem cells have enhanced self-renewal capacity and oncogenic potentials.
Hsu YC; Chen TC; Lin CC; Yuan CT; Hsu CL; Hou HA; Kao CJ; Chuang PH; Chen YR; Chou WC; Tien HF
Blood Adv; 2019 Aug; 3(15):2355-2367. PubMed ID: 31395598
[No Abstract] [Full Text] [Related]
8. FHL2 regulates hematopoietic stem cell functions under stress conditions.
Hou Y; Wang X; Li L; Fan R; Chen J; Zhu T; Li W; Jiang Y; Mittal N; Wu W; Peace D; Qian Z
Leukemia; 2015 Mar; 29(3):615-24. PubMed ID: 25179730
[TBL] [Abstract][Full Text] [Related]
9. Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells.
Zhang Y; Yan X; Sashida G; Zhao X; Rao Y; Goyama S; Whitman SP; Zorko N; Bernot K; Conway RM; Witte D; Wang QF; Tenen DG; Xiao Z; Marcucci G; Mulloy JC; Grimes HL; Caligiuri MA; Huang G
Blood; 2012 Aug; 120(5):1118-29. PubMed ID: 22740449
[TBL] [Abstract][Full Text] [Related]
10. Runx1 downregulates stem cell and megakaryocytic transcription programs that support niche interactions.
Behrens K; Triviai I; Schwieger M; Tekin N; Alawi M; Spohn M; Indenbirken D; Ziegler M; Müller U; Alexander WS; Stocking C
Blood; 2016 Jun; 127(26):3369-81. PubMed ID: 27076172
[TBL] [Abstract][Full Text] [Related]
11. Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation.
Nagase R; Inoue D; Pastore A; Fujino T; Hou HA; Yamasaki N; Goyama S; Saika M; Kanai A; Sera Y; Horikawa S; Ota Y; Asada S; Hayashi Y; Kawabata KC; Takeda R; Tien HF; Honda H; Abdel-Wahab O; Kitamura T
J Exp Med; 2018 Jun; 215(6):1729-1747. PubMed ID: 29643185
[No Abstract] [Full Text] [Related]
12. ASXL2 regulates hematopoiesis in mice and its deficiency promotes myeloid expansion.
Madan V; Han L; Hattori N; Teoh WW; Mayakonda A; Sun QY; Ding LW; Nordin HBM; Lim SL; Shyamsunder P; Dakle P; Sundaresan J; Doan NB; Sanada M; Sato-Otsubo A; Meggendorfer M; Yang H; Said JW; Ogawa S; Haferlach T; Liang DC; Shih LY; Nakamaki T; Wang QT; Koeffler HP
Haematologica; 2018 Dec; 103(12):1980-1990. PubMed ID: 30093396
[TBL] [Abstract][Full Text] [Related]
13. Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice.
Wang J; Li Z; He Y; Pan F; Chen S; Rhodes S; Nguyen L; Yuan J; Jiang L; Yang X; Weeks O; Liu Z; Zhou J; Ni H; Cai CL; Xu M; Yang FC
Blood; 2014 Jan; 123(4):541-53. PubMed ID: 24255920
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia.
Liao R; Xu Y; Chen M; Chen X; Zhan X; Sun J
Hematology; 2013 Jul; 18(4):191-7. PubMed ID: 23321417
[TBL] [Abstract][Full Text] [Related]
15. Inverse and correlative relationships between TRIBBLES genes indicate non-redundant functions during normal and malignant hemopoiesis.
Salomé M; Hopcroft L; Keeshan K
Exp Hematol; 2018 Oct; 66():63-78.e13. PubMed ID: 30031847
[TBL] [Abstract][Full Text] [Related]
16. Aberrant histone modifications induced by mutant ASXL1 in myeloid neoplasms.
Asada S; Kitamura T
Int J Hematol; 2019 Aug; 110(2):179-186. PubMed ID: 30515738
[TBL] [Abstract][Full Text] [Related]
17. Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo.
Abdel-Wahab O; Gao J; Adli M; Dey A; Trimarchi T; Chung YR; Kuscu C; Hricik T; Ndiaye-Lobry D; Lafave LM; Koche R; Shih AH; Guryanova OA; Kim E; Li S; Pandey S; Shin JY; Telis L; Liu J; Bhatt PK; Monette S; Zhao X; Mason CE; Park CY; Bernstein BE; Aifantis I; Levine RL
J Exp Med; 2013 Nov; 210(12):2641-59. PubMed ID: 24218140
[TBL] [Abstract][Full Text] [Related]
18. A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies.
Bahr C; von Paleske L; Uslu VV; Remeseiro S; Takayama N; Ng SW; Murison A; Langenfeld K; Petretich M; Scognamiglio R; Zeisberger P; Benk AS; Amit I; Zandstra PW; Lupien M; Dick JE; Trumpp A; Spitz F
Nature; 2018 Jan; 553(7689):515-520. PubMed ID: 29342133
[TBL] [Abstract][Full Text] [Related]
19. Loss of the tumor suppressor BAP1 causes myeloid transformation.
Dey A; Seshasayee D; Noubade R; French DM; Liu J; Chaurushiya MS; Kirkpatrick DS; Pham VC; Lill JR; Bakalarski CE; Wu J; Phu L; Katavolos P; LaFave LM; Abdel-Wahab O; Modrusan Z; Seshagiri S; Dong K; Lin Z; Balazs M; Suriben R; Newton K; Hymowitz S; Garcia-Manero G; Martin F; Levine RL; Dixit VM
Science; 2012 Sep; 337(6101):1541-6. PubMed ID: 22878500
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
